These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 9383684

  • 1. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
    van't Hof RJ, Ralston SH.
    J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684
    [Abstract] [Full Text] [Related]

  • 2. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption.
    Löwik CW, Nibbering PH, van de Ruit M, Papapoulos SE.
    J Clin Invest; 1994 Apr; 93(4):1465-72. PubMed ID: 8163651
    [Abstract] [Full Text] [Related]

  • 3. Nitric oxide: a cytokine-induced regulator of bone resorption.
    Ralston SH, Ho LP, Helfrich MH, Grabowski PS, Johnston PW, Benjamin N.
    J Bone Miner Res; 1995 Jul; 10(7):1040-9. PubMed ID: 7484279
    [Abstract] [Full Text] [Related]

  • 4. Nitric oxide and bone.
    Evans DM, Ralston SH.
    J Bone Miner Res; 1996 Mar; 11(3):300-5. PubMed ID: 8852940
    [Abstract] [Full Text] [Related]

  • 5. Involvement of iNOS-dependent NO production in the stimulation of osteoclast survival by TNF-alpha.
    Lee SK, Huang H, Lee SW, Kim KH, Kim KK, Kim HM, Lee ZH, Kim HH.
    Exp Cell Res; 2004 Aug 15; 298(2):359-68. PubMed ID: 15265685
    [Abstract] [Full Text] [Related]

  • 6. Nitric oxide promotes infectious bone resorption by enhancing cytokine-stimulated interstitial collagenase synthesis in osteoblasts.
    Lin SK, Kok SH, Kuo MY, Lee MS, Wang CC, Lan WH, Hsiao M, Goldring SR, Hong CY.
    J Bone Miner Res; 2003 Jan 15; 18(1):39-46. PubMed ID: 12510804
    [Abstract] [Full Text] [Related]

  • 7. Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha.
    Maciejewski JP, Selleri C, Sato T, Cho HJ, Keefer LK, Nathan CF, Young NS.
    J Clin Invest; 1995 Aug 15; 96(2):1085-92. PubMed ID: 7543491
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Regulation of bone resorption and osteoclast survival by nitric oxide: possible involvement of NMDA-receptor.
    Mentaverri R, Kamel S, Wattel A, Prouillet C, Sevenet N, Petit JP, Tordjmann T, Brazier M.
    J Cell Biochem; 2003 Apr 15; 88(6):1145-56. PubMed ID: 12647297
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A novel synthetic triazolotriazepine derivative JTT-606 inhibits bone resorption by down-regulation of action and production of bone resorptive factors.
    Chikazu D, Shindo M, Iwasaka T, Katagiri M, Manabe N, Takato T, Nakamura K, Kawaguchi H.
    J Bone Miner Res; 2000 Apr 15; 15(4):674-82. PubMed ID: 10780859
    [Abstract] [Full Text] [Related]

  • 14. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.
    Balga R, Wetterwald A, Portenier J, Dolder S, Mueller C, Hofstetter W.
    Bone; 2006 Aug 15; 39(2):325-35. PubMed ID: 16580896
    [Abstract] [Full Text] [Related]

  • 15. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
    Lee JH, Jin H, Shim HE, Kim HN, Ha H, Lee ZH.
    Mol Pharmacol; 2010 Jan 15; 77(1):17-25. PubMed ID: 19828731
    [Abstract] [Full Text] [Related]

  • 16. The flurbiprofen derivatives HCT1026 and HCT1027 inhibit bone resorption by a mechanism independent of COX inhibition and nitric oxide production.
    Idris AI, Del Soldato P, Ralston SH, van't Hof RJ.
    Bone; 2004 Sep 15; 35(3):636-43. PubMed ID: 15336599
    [Abstract] [Full Text] [Related]

  • 17. IL-12- and IL-18-mediated, nitric oxide-induced apoptosis in TNF-α-mediated osteoclastogenesis of bone marrow cells.
    Kitaura H, Fujimura Y, Yoshimatsu M, Kohara H, Morita Y, Aonuma T, Fukumoto E, Masuyama R, Yoshida N, Takano-Yamamoto T.
    Calcif Tissue Int; 2011 Jul 15; 89(1):65-73. PubMed ID: 21611811
    [Abstract] [Full Text] [Related]

  • 18. Osteocytes subjected to fluid flow inhibit osteoclast formation and bone resorption.
    Tan SD, de Vries TJ, Kuijpers-Jagtman AM, Semeins CM, Everts V, Klein-Nulend J.
    Bone; 2007 Nov 15; 41(5):745-51. PubMed ID: 17855178
    [Abstract] [Full Text] [Related]

  • 19. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts.
    Onoe Y, Miyaura C, Kaminakayashiki T, Nagai Y, Noguchi K, Chen QR, Seo H, Ohta H, Nozawa S, Kudo I, Suda T.
    J Immunol; 1996 Jan 15; 156(2):758-64. PubMed ID: 8543830
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.